Judith Leitner

11PUBLICATIONS
55CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursProteomics and intermolecular interactions (excl. medical proteomics)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 14, 2026
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

|Dec 10, 2024
Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway.

Yoshitaka Adachi, Seitaro Terakura, Masahide Osaki

|Nov 19, 2024
LAG-3-An incompletely understood target in cancer therapy.

Judith Leitner, Katharina Aigner-Radakovics, Peter Steinberger

|Nov 28, 2023
Interrogating ligand-receptor interactions using highly sensitive cellular biosensors.

Maximilian A Funk, Judith Leitner, Marlene C Gerner

|Oct 03, 2023
The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif.

Katharina Aigner-Radakovics, Annika De Sousa Linhares, Benjamin Salzer

|Oct 12, 2022
Interoperability of RTN1A in dendrite dynamics and immune functions in human Langerhans cells.

Małgorzata Anna Cichoń, Karin Pfisterer, Judith Leitner

Pageof 2

Frequent Collaborators

11 joint publications

Peter Steinberger

2 joint publications

Benjamin Salzer

2 joint publications

Manfred Lehner

2 joint publications

Karin Pfisterer